Send me a link:

*Text messaging rates may apply.

 Dow Down 0.48% Nasdaq Up 0.14%

Synta Pharmaceuticals Corp. (SNTA)

-NasdaqGM
4.00 Down 0.02(0.50%) 11:59AM EDT - Nasdaq Real Time Price
Prev Close:4.02
Open:4.06
Bid:4.01 x 5200
Ask:4.02 x 11500
1y Target Est:12.70
Beta:1.62
Next Earnings Date:N/A
Day's Range:3.95 - 4.10
52wk Range:3.70 - 7.30
Volume:864,742
Avg Vol (3m):1,565,480
Market Cap:350.23M
P/E (ttm):N/A
EPS (ttm):-1.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SNTA

Comparison

Symbol% ChgMkt Cap
SNTADown 0.50%350.23M
INFIUp 1.61%460.66M
NVSDown 0.16%213.68B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.09
Quarterly EPS Est (Jun-14) :-0.27
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs for treating severe medical conditions, including cancer and chronic inflammatory diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback